P-D-R Pharma Documentation Ring

The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations.

Latest News from the P-D-R Company Websites

Published 31 July 2014 | 2:57 pm

BASF predicts Rust Belt cities, unpretentious innovation and sustainable living will help drive North American color choices for 2018 model year vehicles

"Under the Radar" showcases BASF's automotive color trends Global theme predict human-centered society will value individuality and sensibility more ...

Published 31 July 2014 | 9:31 am

Media Release

When science and art intersect and provoke: "Roche Continents" challenge 100 students at the Salzburg Festival more ...

Published 31 July 2014 | 8:48 am

AstraZeneca PLC second quarter and half year results 2014

Pascal Soriot, Chief Executive Officer, commenting on the results, said: more ...

Published 31 July 2014 | 7:32 am

Solid sales and Business EPS(1) growth at CER in Q2 2014

to euro8,075 million driven by Genzyme (+29.1%) and Diabetes (+16.2%). more ...

Published 30 July 2014 | 10:06 pm

Sanofi and Regeneron Announce Plan to Use Priority Review Voucher

- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the companies intend to use a U.S. Food and Drug more ...

Published 30 July 2014 | 3:45 pm

High School Students Address Real-World STEM Problems in Baxter Partnership

Baxter and other participating companies recently came together with 125 Chicago-area high school students to mark the conclusion of the first year of the Illinois Science and more ...

Published 30 July 2014 | 3:01 pm

BASF supports the use of HEAT® herbicide as a pre-harvest application for the 2014 season

Import tolerances now established for field peas, dry beans, sunflowers and soybeans more ...

Published 30 July 2014 | 2:45 pm

Baxter Announces Divestiture of Commercial Vaccines Business to Pfizer

DEERFIELD, Ill., July 30, 2014 - Baxter International Inc. (NYSE:BAX) today announced that it has entered into a definitive agreement to sell its two commercially marketed more ...

Published 30 July 2014 | 2:38 pm

Pfizer Enters Into Agreement To Acquire Baxter's Portfolio Of Marketed Vaccines

Pfizer Inc. today announced that it has entered into a definitive agreement to acquire Baxter International Inc.'s portfolio of marketed vaccines for $635 million. As part of the more ...

Published 30 July 2014 | 2:06 pm

Paris and Tarrytown, New York - July 30, 2014

Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that nine new Phase 3 ODYSSEY trials of alirocumab in people more ...

Pharma Documentation Ring:
22 companies - 5 common aims:

  • Promote exchange of experience/networking among members
  • Encourage commercial development of new information services and systems
  • Jointly assess new and existing products and services
  • Provide a forum for the information industry
  • How to become a P-D-R member?
Next Annual General Meeting, Sept. 23-26, 2014, Windsor, UK

Next Annual General Meeting, Sept. 23-26, 2014, Windsor, UK